-
Pneumoconiosis Definition
- -Retention of and pathologic effects from inhalation of dust particles
- -typically due to inorganic dusts
- -most don't develop disease
-
Hypersensitivity Pneumonitis Definition
- -Complex syndromes with various antigens
- -Organic antigens (proteins from bacteria, mold, fungi, myocbacterium)
-
General Pathogenesis
- Development depends on:
- 1. Amount of dust retained in the lung -concentration
- -duration of exposure
- -effectiveness of clearance mechanisms
- 2. Size, shape and buoyancy of particles
- -1-5um
- -asbestos is larger by narrower width
- -curly fibers not dangerous
- 3. Particle solubility and physiochemical properties
- -smaller/soluble: dissolve in blood
- -larger/non-soluble: inflammation and fibrosis
- -quartz: interact with free radicals
-
Protection Mechanisms
- 1. Tortuous passages of upper airways
- 2. Bronchoconstriction
- 3. Entrapment in mucus blanket
- 4. Mucocilliary clearance
- 5. Phagocytosis by macrophages
- 6. Transport to lymphatics
- 7. Metabolic modifications
-
Pathophysiology of Environmental Lung Disease
- -typical reaction to chronic injury is fibrosis
- -mechanism depends on agent
- -some directly injure lung parenchyma
- -some trigger macrophages --> inflammatory response
- -fibrosis may lead to pulmonary HTN and death from respiratory failure or RHF
-
Coal Workers Pneumoconiosis
-"black lung"
- Range of Disease:
- 1. Asymptomatic anthracosis
- 2. Simple coal workers pneumoconiosis
- 3. Complicated coal workers pneumoconiosis/Progressive Massive Fibrosis
-
Anthracosis
- -asymptomatic
- -coal workers lung, urban dwellers, tobacco smokers
- -carbon pigment taken up in MPs which accumulate in lymphatics in CT and LNs

-
Simple Coal Workers Pneumoconiosis
- -usually asymptomatic
- -may have chronic productive cough with blank-tinged sputum
- Coal macules
- -1-2mm
- -carbon laden macrophages

- Coal nodules
- -<1cm
- -collagen fibers and carbon laden macrophages

-
Complicated Coal Workers Pneumoconiosis/Progressive Massive Fibrosis
-develops in the background of simple CWP
- Symptoms:
- -dyspnea
- -cough
- -sputum
- -may develop R sided congestive HF
*may progress even after exposure is stopped
- Diagnosis:
- -coal nodules > 1cm
- -nodules contain dense collagen and pigment and may have central necrosis

-
Silicosis
- -most prevalent pneumoconiosis in the world
- -sandblasters, mine workers
- -inhalation of silicon dioxide
- Two forms of silica:
- 1. Crystalline (more fibrogenic)
- 2. Amorphous (can cause fibrosis with heavy burden)
- Pathogenesis:
- -silica is toxic to macrophages
- -fibrosis
- -lesions in upper portion of lungs
- Gross:
- -hard collagenous scars

- Histology:
- -concentric layers of hyalinized collagen
- -particles visible under polarized light

*Increased susceptibility to TB (maybe due to depressed cell mediated immunity)
-
Asbestosis
- Different types of fibers
- 1. Serpentines
- -curly and flexible
- -get stuck in upper respiratory tract and cleared
- 2. Amphobiles
- -straight stiff and brittle
- -less prevalent
- -more pathogenic (mesothelioma)
- Pathophysiology:
- -crystals activate macrophages
- -stimulate production of ROS and cytokines
- -promote fibroblast and mesothelial cell proliferation
- Histology:
- -Ferruginous bodies: iron from phagocyte ferritin coats fibers
- -more commonly in lung parenchyma

- Pathology of chronic exposure:
- 1. Benign pleural effusions (asbestos pleurisy)
- 2. Focal or diffuse pulmonary interstitial fibrosis (lower lobes)
- 3. Parietal pleural plaques
- 4. Mesothelioma
-
Focal or Diffuse Pulmonary Interstitial Fibrosis
- -affects lower lobes and subpleural lung first
- -begins as fibrosis around respiratory bronchioles
- -extends to involve adjacent alveolar sacs and alveoli
- -fibrosis creates enlarged airspaces enclosed within thick fibrous walls
-
Pleural Plaques
- -most common manifestation of asbestos
- -typically parietal
- -typically do NOT contain ferruginous obides
- -eventually calcify
- -dense periauricular collagen with slit like retraction spaces parallel to pleural surface
 
-
Malignant Mesothelioma
- Epidemiology:
- -rare neoplasm
- -2-10% of pts with heavy asbestos exposure
- -long latency: 25-45yrs
- -other risk factors: radiation, chronic inflammation
*No increase in risk in asbestos workers who smoke
- Clinical Presentation:
- -pleural effusion
- -chest pain
- -dyspnea
- Pathogenesis:
- -asbestos causes chronic irritation of mesothelial cells
- -generate ROS --> DNA damage
- -can eventually encase the lung
- Gross:
- -multiple gray-white ill defined noduels
- -diffusely thickened pleura

- Three Main Histological Types:
- 1. Epithelial (resembles adenocarcinoma)
- 2. Sarcomatoid (spindle cells)
- 3. Mixed or biphasic
- *has no prognostic value
-
Epithelial Mesothelioma
- -sheets of rounded cells infiltrating down into fat

- -can mimic adenocarcinoma

-
Sarcomatoid Mesothelioma
- -spindle fibers
- -not in sheets
-
Asbestos and Lung Carcinoma
- -most frequent malignancy in asbestos exposure
- -risk for developing lung carcinoma is exacerbated by cigarette smoking (50-90X)
- -carcinogens from smoke may absorb into asbestos fibers
- -1/5 exposed die of lung carcinoma
- -1/10 die of mesothelioma
- -1/10 die of GI carcinomas
-
Hypersensitivity Pneumonitis
All the funny names
- -Immunologic reaction to inhaled organic antigens
- -both type III and type IV hypersensitivity responses
- Type III
- -immune complex mediated
- -abs present in blood
- -C' and Ig in vessel walls
- Type IV:
- -cell mediated
- -"attempt" to form a granulomatous response
- -increased chemokines and T cells in BAL
- -non-caseating granulomas are present
- Diagnosis:
- -known exposure
- -BAL with T lymphocytosis (CD8>CD4)
- -positive inhalation test
- Histopathology:
- -diffuse mononuclear cell infiltrates (lymphocytes)

- -poorly formed non-caseating granulomas (peribronchiolar localization)

-interstitial fibrosis and obliterative bronchiolitis in advanced cases
-
Treatment of HP
- -remove source of antigen
- -corticosteroids
- -prognosis good unless fibrosis has already developed
-
Iatrogenic/Drug-Induced Lung Disease
- Drugs:
- Bleomycin
- Methotrexate
- AMiodarone
- Nitrofurantoin
- Aspirin
- β-blockers
Radiation
|
|